The page is the record's research on the issuer — no analyst, no rating, no view. # Drugs Made In America Acquisition II Corp. (NASDAQ: DMII) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Drugs Made In America Acquisition II Corp. is listed on NASDAQ under ticker DMII, with ISIN USG2851K1046. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US. The security type is SPAC (by SIC 6770), sector 6770 Blank Checks; segment and jurisdiction are not on the record. Listing status is listed, not halted. ## The disclosure read The record holds 12 filings across 10 filing days in the window 2025-11-08 to 2026-11-08: 4 corporate news, 2 director change, 2 regulatory filing and 4 results. The median gap between filing days is 13 days. The latest filing is dated 2026-08-14 and is of type results, 86 days before the record date of 2026-11-08. The NASDAQ median is 6.0 days between filing days, 52 filings, and 5.0 days latency across 4359 issuers. The 6770 Blank Checks median is 6.5 days between filing days, 26 filings, and 44 days latency across 819 issuers. ## Auditor The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. Halt status: listed, not halted. ## Orderability The outcome is not determinable, as the chapter's orderability section carries no client_categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's sealed years are 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0002040475.json (identity.name) - https://mcp.us-cm-kg.ai/events/NASDAQ/DMII (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/DMII (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/DMII · public-record only · the same page signed and receipted: get_research at https://mcp.getissuer.ai/mcp